SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-115853
Filing Date
2024-04-26
Accepted
2024-04-26 08:00:50
Documents
6
Period of Report
2024-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d819163ddef14a.htm DEF 14A 327308
2 GRAPHIC g819163sp1.jpg GRAPHIC 975
3 GRAPHIC g819163sp1g001.jpg GRAPHIC 720
4 GRAPHIC g819163sp1g01.jpg GRAPHIC 943
5 GRAPHIC g819163sp1g02.jpg GRAPHIC 1206
6 GRAPHIC g819163sp1g03.jpg GRAPHIC 912
  Complete submission text file 0001193125-24-115853.txt   335692
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41390 | Film No.: 24878864
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)